World News | Katharine Gemmell, Bloomberg | Tuesday June 29, 2021
Mixing doses of Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc creates a strong immune response, according to results from a University of Oxford study, a finding that could enable greater flexibility in the use of scarce supplies.
www.ndtv.com